+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Gastrointestinal stromal tumors: recent advances in understanding of their biology



Gastrointestinal stromal tumors: recent advances in understanding of their biology



Human Pathology 30(10): 1213-1220



Gastrointestinal stromal tumor (GIST) is the preferred term for mesenchymal tumors specific for the gastrointestinal tract (60% in stomach, 30% small intestine, 10% elsewhere). GISTs include most tumors previously designated as leiomyoma, cellular leiomyoma, leiomyoblastoma, and leiomyosarcoma. However, in the esophagus, leiomyoma is the most common mesenchymal tumor. GISTs are composed of spindle (70%) or epithelioid (30%) cells, and 10%-30% are malignant showing intra-abdominal spread or liver metastases. They are immunohistochemically positive for c-kit (CD117), CD34, and sometimes for actin but are almost always negative for desmin and S100-protein. The malignant GISTs especially show activating mutations in the c-kit gene. GISTs and gastrointestinal autonomic nerve tumors (GANT) overlap. The cell of origin is not fully understood, but resemblance to the interstitial cells of Cajal, expression of some smooth muscle markers, and occurrence outside of the GI-tract suggest origin from multipotential cells that can differentiate into Cajal and smooth muscle cells.

(PDF emailed within 0-6 h: $19.90)

Accession: 010697352

Download citation: RISBibTeXText

PMID: 10534170

DOI: 10.1016/s0046-8177(99)90040-0


Related references

Recent advances in therapy for gastrointestinal stromal tumors. Current Oncology Reports 9(3): 165-169, 2007

Recent advances in the management of gastrointestinal stromal tumors. Current Oncology Reports 5(4): 288-294, 2003

Recent advances in the management of gastrointestinal stromal tumors. F1000 Medicine Reports 2: -, 2010

Recent advances in the treatment of gastrointestinal stromal tumors. Therapeutic Advances in Medical Oncology 6(3): 115-127, 2014

Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST). Cancer Biology & Therapy 3(3): 251-258, 2004

Gastrointestinal stromal tumors A model for understanding solid tumor biology and development of targeted therapies, or just another low-hanging fruit?. Asia-Pacific Journal of Clinical Oncology 4(4): 185-187, 2008

Recent advances in managing gastrointestinal stromal tumor. F1000research 6: 1689-1689, 2017

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Annals of Diagnostic Pathology 11(1): 27-33, 2007

New advances in biology and treatment of gastrointestinal stromal tumours (GISTs). Minerva Chirurgica 62(3): 179-186, 2007

Recent advances and novel agents for gastrointestinal stromal tumor GIST. Journal of Hematology & Oncology 5(1): 21, 2012

Recent advances and novel agents for gastrointestinal stromal tumor (GIST). Journal of Hematology & Oncology 5: 21-21, 2012

Gastrointestinal stromal tumor: recent advances in pathology and genetics. Pathology International 65(1): 9-18, 2015

Advances and Challenges on Management of Gastrointestinal Stromal Tumors. Frontiers in Oncology 8: 135-135, 2018

Latest advances in adult gastrointestinal stromal tumors. Future Oncology 13(24): 2183-2193, 2017

Advances in adjuvant therapy of gastrointestinal stromal tumors. Current Oncology Reports 14(4): 327-332, 2012